{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T10:19:09Z","timestamp":1773224349073,"version":"3.50.1"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T00:00:00Z","timestamp":1773100800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Aims and Background<\/jats:title>\n                    <jats:p>This study aimed to provide a preliminary clarification of the predictive factors for the development of cirrhosis within 1-year cirrhosis in non-cirrhotic HBV-associated acute-on-chronic liver failure (HBV-ACLF) patients and develop a risk stratification algorithm.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Non-cirrhotic HBV-ACLF patients who survived for at least 1 year and had complete clinical records were included from January 2016 to December 2023 at Beijing Youan Hospital, Capital Medical University. Multivariate logistic regression was performed to identify independent predictors of cirrhosis progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 329 HBV-ACLF patients initially screened, 109 were enrolled in the study, and a 1-year follow-up revealed that 21.1% of the non-cirrhotic patients developed cirrhosis. Multivariate logistic regression identified independent predictors of cirrhosis progression: non-resolution of total bilirubin (TB) levels within 28 days [5.64 (1.39\u201325.00)], failure to normalize the international normalized ratio (INR) within 28 days [6.34 (1.52\u201329.50)], and baseline platelet (PLT) count [0.98 (0.97\u20130.99)]. ROC analysis demonstrated strong predictive accuracy for cirrhosis with INR normalization (AUC = 0.82), TB resolution (AUC = 0.78), and baseline PLT count (AUC = 0.75). A risk stratification pathway incorporating INR normalization and baseline PLT effectively categorized patients into low, medium, and high-risk groups, with corresponding cirrhosis incidence rates of 5.4%, 29.4%, and 77.8%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The findings underscore the importance of INR normalization, TB resolution, and baseline PLT count as independent predictors of cirrhosis and provide a useful framework for clinical decision-making and early intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1743728","type":"journal-article","created":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:26:58Z","timestamp":1773149218000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factors for the development of cirrhosis within 1-year in non-cirrhotic patients with HBV- related acute-on-chronic liver failure"],"prefix":"10.3389","volume":"13","author":[{"given":"Wenling","family":"Wang","sequence":"first","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Liver Regeneration and Artificial Liver Transformation Research","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolin","family":"Wang","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Liver Regeneration and Artificial Liver Transformation Research","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Liver Regeneration and Artificial Liver Transformation Research","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huaibin","family":"Zou","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Liver Regeneration and Artificial Liver Transformation Research","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manman","family":"Xu","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Liver Regeneration and Artificial Liver Transformation Research","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[{"name":"Fourth Department of Liver Disease, Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]},{"name":"Beijing Key Laboratory of Liver Regeneration and Artificial Liver Transformation Research","place":["Beijing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-024-10773-4","article-title":"Acute-on-chronic liver failure (ACLF): the \u2018Kyoto Consensus'-steps from Asia","volume":"19","author":"Choudhury","year":"2025","journal-title":"Hepatol Int"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2022.06.017","article-title":"Trends in the disease burden of HBV and HCV infection in China from 1990-2019","author":"Yue","year":"2022","journal-title":"Int J Infect Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1007\/s12072-013-9424-5","article-title":"Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey","volume":"7","author":"You","year":"2013","journal-title":"Hepatol Int"},{"key":"B4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s12985-016-0536-0","article-title":"Changing etiologies and outcome of liver failure in Southwest China","volume":"13","author":"Xie","year":"2016","journal-title":"Virol J"},{"key":"B5","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1186\/s12876-023-03024-7","article-title":"Efficacy and safety of tenofovir disoproxil fumarate versus entecavir in the treatment of acute-on-chronic liver failure with hepatitis B: a systematic review and meta-analysis","volume":"23","author":"Wang","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12876-021-02007-w","article-title":"A neutrophil-to-lymphocyte ratio-based prognostic model to predict mortality in patients with HBV-related acute-on-chronic liver failure","volume":"21","author":"Sun","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/SHK.0000000000000993","article-title":"Neutrophil-to-lymphocyte ratio predicts death in acute-on-chronic liver failure patients admitted to the intensive care unit: a retrospective cohort study","volume":"49","author":"Moreau","year":"2018","journal-title":"Shock"},{"key":"B8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12876-020-01437-2","article-title":"A novel predictive model based on inflammatory markers to assess the prognosis of patients with HBV-related acute-on-chronic liver failure: a retrospective cohort study","volume":"20","author":"Qiang","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.cgh.2022.03.016","article-title":"Predicting the onset of hepatitis B virus-related acute-on-chronic liver failure","volume":"21","author":"Luo","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2021.05.026","article-title":"Development and validation of a new prognostic score for hepatitis B virus-related acute-on-chronic liver failure","volume":"75","author":"Li","year":"2021","journal-title":"J Hepatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"15198","DOI":"10.1038\/s41598-024-63900-4","article-title":"Construction of a novel prognostic scoring model for HBV-ACLF liver failure based on dynamic data","volume":"14","author":"Cai","year":"2024","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1136\/gutjnl-2025-335651","article-title":"Performance of the China-CLIF framework in acute-on-chronic liver failure: a multicohort study across all aetiologies","volume":"75","author":"Luo","year":"2025","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","first-page":"21265","DOI":"10.1038\/s41598-023-47463-4","article-title":"A nomogram based on psoas muscle index predicting long-term cirrhosis incidence in non-cirrhotic patients with HBV-related acute-on-chronic liver failure","volume":"13","author":"Bai","year":"2023","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100535","DOI":"10.1016\/j.aohep.2021.100535","article-title":"and Freeman RB. From child-pugh to MELD score and beyond: taking a walk down memory lane","volume":"27","author":"Ruf","year":"2022","journal-title":"Ann Hepatol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"7088","DOI":"10.3748\/wjg.v26.i45.7088","article-title":"Chinese guidelines on the management of liver cirrhosis (abbreviated version)","volume":"26","author":"Xu","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"key":"B20","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/hep4.1829","article-title":"Low serum cholinesterase identifies patients with worse outcome and increased mortality after TIPS","volume":"6","author":"Stockhoff","year":"2022","journal-title":"Hepatol Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.03.005","article-title":"aMAP score and its combination with liver stiffness measurement accurately assess liver fibrosis in chronic hepatitis B patients","author":"Fan","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"762291","DOI":"10.3389\/fmed.2021.762291","article-title":"Increased INR values predict accelerating deterioration and high short-term mortality among patients hospitalized with cirrhosis or advanced fibrosis","volume":"8","author":"Wang","year":"2021","journal-title":"Front Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.14218\/JCTH.2020.00179","article-title":"Clinical course and outcome patterns of acute-on-chronic liver failure: a multicenter retrospective cohort study","volume":"9","author":"Xu","year":"2021","journal-title":"J Clin Transl Hepatol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"101476","DOI":"10.1016\/j.eclinm.2022.101476","article-title":"Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: the TEA cohort to evaluate long-term post-transplant outcomes","volume":"49","author":"Xia","year":"2022","journal-title":"EClinicalMedicine"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1056\/NEJMra1914900","article-title":"Acute-on-chronic liver failure","volume":"382","author":"Arroyo","year":"2020","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.cgh.2013.02.026","article-title":"Coagulation in liver disease: a guide for the clinician","volume":"11","author":"Northup","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.4254\/wjh.v16.i9.1229","article-title":"Hematological abnormalities in liver cirrhosis","volume":"16","author":"Fierro-Angulo","year":"2024","journal-title":"World J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/HEP.0000000000000548","article-title":"Development and validation of a prognostic score to identify the optimal candidate for preemptive TIPS in patients with cirrhosis and acute variceal bleeding","volume":"79","author":"Lv","year":"2024","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"101500","DOI":"10.1016\/j.redox.2020.101500","article-title":"Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress","volume":"32","author":"Wu","year":"2020","journal-title":"Redox Biol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1177\/10815589231180498","article-title":"Hyperbilirubinemia in hospitalized patients: Etiology and outcomes","volume":"71","author":"Kwon","year":"2023","journal-title":"J Investig Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1286510","DOI":"10.3389\/fmed.2023.1286510","article-title":"Association of direct bilirubin to total bilirubin ratio with 90-day mortality in patients with acute-on-chronic liver failure","volume":"10","author":"Ma","year":"2023","journal-title":"Front Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/liv.15818","article-title":"Machine-learning model comprising five clinical indices and liver stiffness measurement can accurately identify MASLD-related liver fibrosis","volume":"44","author":"Fan","year":"2024","journal-title":"Liver Int"},{"key":"B33","doi-asserted-by":"publisher","first-page":"599","DOI":"10.5009\/gnl20171","article-title":"Direct bilirubin is more valuable than total bilirubin for predicting prognosis in patients with liver cirrhosis","volume":"15","author":"Lee","year":"2021","journal-title":"Gut Liver"},{"key":"B34","doi-asserted-by":"publisher","first-page":"12","DOI":"10.14744\/hf.2020.2020.0027","article-title":"ATA Index: a novel score for predicting fibrosis stage in chronic viral hepatitis","volume":"2","author":"Yarkan Tugsal","year":"2021","journal-title":"Hepatol Forum"},{"key":"B35","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3390\/ijms17122057","article-title":"The relationship between serum bilirubin and elevated fibrotic indices among hbv carriers: a cross-sectional study of a Chinese population","volume":"17","author":"Du","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"e0200364","DOI":"10.1371\/journal.pone.0200364","article-title":"Evolution of platelet functions in cirrhotic patients undergoing liver transplantation: a prospective exploration over a month","volume":"13","author":"Eyraud","year":"2018","journal-title":"PLoS ONE"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S376068","article-title":"Design for a multicentre prospective cohort for the assessment of platelet function in patients with hepatitis-B-virus-related acute-on-chronic liver failure","author":"Jiang","year":"2022","journal-title":"Clin Epidemiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.06.013","article-title":"AGILE 3+ Score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD","author":"Pennisi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"e0055","DOI":"10.1097\/HC9.0000000000000055","article-title":"Increased accuracy in identifying NAFLD with advanced fibrosis and cirrhosis: independent validation of the Agile 3+ and 4 scores","volume":"7","author":"Noureddin","year":"2023","journal-title":"Hepatol Commun"},{"key":"B40","doi-asserted-by":"publisher","first-page":"101482","DOI":"10.1016\/j.clinre.2020.06.008","article-title":"The dynamic of platelet count as a novel and valuable predictor for 90-day survival of hepatitis B virus-related acute-on-chronic liver failure patients","volume":"45","author":"Xu","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7394904","DOI":"10.1155\/2018\/7394904","article-title":"Low platelet to white blood cell ratio indicates poor prognosis for acute-on-chronic liver failure","volume":"2018","author":"Jie","year":"2018","journal-title":"Biomed Res Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1080\/17474124.2018.1533813","article-title":"Therapeutic implication of platelets in liver regeneration -hopes and hues","volume":"12","author":"Aryal","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.3390\/ijms23052861","article-title":"Isolation of platelet-derived exosomes from human platelet-rich plasma: biochemical and morphological characterization","volume":"23","author":"Saumell-Esnaola","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.3390\/v14020333","article-title":"Factors associated with significant platelet count improvement in thrombocytopenic chronic hepatitis c patients receiving direct-acting antivirals","volume":"14","author":"Chen","year":"2022","journal-title":"Viruses"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1080484","DOI":"10.3389\/fmicb.2022.1080484","article-title":"Human liver tissue transcriptomics revealed immunometabolic disturbances and related biomarkers in hepatitis B virus-related acute-on-chronic liver failure","volume":"13","author":"Yang","year":"2022","journal-title":"Front Microbiol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/gutjnl-2020-323395","article-title":"PBMC transcriptomics identifies immune-metabolism disorder during the development of HBV-ACLF","volume":"71","author":"Li","year":"2022","journal-title":"Gut"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.22541\/au.173744201.14946110\/v1","article-title":"Risk factors for the development of cirrhosis within one-year in non-cirrhotic patients with HBV-related acute-on-chronic liver failure","author":"Wang","year":"2025","journal-title":"Authorea"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1743728\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T13:27:00Z","timestamp":1773149220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1743728\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,10]]},"references-count":47,"alternative-id":["10.3389\/fmed.2026.1743728"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1743728","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,10]]},"article-number":"1743728"}}